Korea’s National Institute of Technology Standards (KATS) revised Annex 3 of the KC Certification Scheme—Cybersecurity Requirements for Intelligent Lab Infrastructure—on May 6, 2026. The update mandates cybersecurity review by Korea Internet & Security Agency (KISA)-accredited labs for Bio-Barrier automatic access control systems, Digital Twin Lab edge computing platforms, and remote decontamination (Decon) control systems before market entry. This development directly affects exporters and system integrators supplying intelligent laboratory infrastructure to South Korea, particularly those based in China.
On May 6, 2026, KATS published an amendment to Annex 3 of the KC Certification requirements, titled Cybersecurity Requirements for Intelligent Lab Infrastructure. The revision explicitly adds three product categories to the scope of mandatory cybersecurity assessment: (1) Bio-Barrier automatic door access systems; (2) Digital Twin Lab edge computing platforms; and (3) remote Decon control systems. Affected products must undergo penetration testing and source code auditing conducted by KISA-certified laboratories. A transition period of 60 days applies from the effective date.
Direct Exporters (e.g., Chinese OEMs and system vendors)
These companies supply Bio-Barrier, Digital Twin Lab, or remote Decon systems directly into the Korean market. They are now required to obtain KISA-aligned cybersecurity validation prior to KC certification—and thus before import clearance. Impact includes delayed shipment timelines, added third-party testing costs, and potential redesign efforts if legacy firmware or architecture fails audit criteria.
Lab Infrastructure Integrators & Solution Providers
Firms assembling turnkey intelligent lab solutions—including combinations of access control, digital twin visualization, and decontamination orchestration—must verify cybersecurity compliance across all integrated subsystems. Even if individual components were previously KC-certified, the new rule applies when deployed as part of an interconnected intelligent lab infrastructure. This raises integration validation complexity and may require re-submission of full-system documentation.
Local Korean Distributors & Aftermarket Support Providers
Distributors handling technical support, firmware updates, or cloud connectivity for these systems now bear heightened responsibility for maintaining post-deployment security posture. KATS’ emphasis on source code audit implies that any remote management interface, OTA update mechanism, or cloud API must align with KISA’s secure development guidelines—potentially triggering contractual and SLA revisions.
The 60-day transition window is short. Stakeholders should track KISA’s publicly listed accredited labs and confirm whether existing test reports (e.g., from ISO/IEC 15408 or IEC 62443 assessments) can be accepted as partial evidence—or whether full KISA-specific testing is required.
Not all Bio-Barrier or Digital Twin Lab variants may fall under the rule—for example, standalone units without network connectivity or remote control functions may remain exempt. Companies should map product families against KATS’ functional definitions in Annex 3 and classify deployments by connectivity scope (e.g., air-gapped vs. cloud-connected).
KISA’s source code audit requirement means vendors must compile and submit software bills of materials (SBOM), build environment records, and vulnerability remediation logs—not just binary test results. Early engagement with a KISA-accredited lab is advised to align on submission formats and timeline expectations.
Where integrators rely on third-party firmware or cloud services (e.g., AWS IoT Core or Azure Digital Twins), contractual terms must clarify who bears responsibility for KISA compliance—especially for patches, logging, and incident response capabilities. Upstream vendor attestations may no longer suffice.
Observably, this amendment signals a shift from device-level safety conformity toward infrastructure-level cyber-resilience in Korea’s regulated lab environment. It does not introduce entirely new standards—but rather enforces existing KISA frameworks (e.g., KISA-2022-017 on embedded system security) within the KC ecosystem. Analysis shows the timing aligns with Korea’s broader push to certify AI-integrated medical and research infrastructure under the National Cybersecurity Strategy 2025–2029. From an industry perspective, this is less a one-off regulatory change and more an early indicator of how KC certification may evolve for other ‘intelligent infrastructure’ categories—such as AI-powered diagnostic devices or automated biosafety cabinets—in coming years. Current monitoring should therefore extend beyond immediate compliance to anticipate adjacent scope expansions.

Conclusion
This update reflects Korea’s tightening alignment between industrial certification and national cybersecurity policy. For international suppliers, it marks a step toward higher assurance thresholds—not just for data privacy, but for operational integrity of interconnected lab systems. It is best understood not as a temporary hurdle, but as a structural recalibration of market access expectations for intelligent infrastructure in Korea.
Information Source:
• Korea Agency for Technology and Standards (KATS), Annex 3 Revision Notice, effective May 6, 2026.
• Pending clarification: KISA’s official list of accredited labs for source code audit and exact acceptance criteria for legacy test reports remain under active publication—this aspect requires ongoing observation.
Get weekly intelligence in your inbox.
No noise. No sponsored content. Pure intelligence.